心力衰竭中的低蛋白血症:病理生理学,临床影响和治疗策略
Mohamad Ghazal1, Wissam I Khalife2
1Department of Medicine, Albany Medical Center, Albany, NY, USA. ghazalm@amc.edu.
Heart failure reviews
|September 6, 2025
概括
在心力衰竭中,低白血症会恶化结果. 素输注可能有助于选择患有严重的患者,但不建议常规使用.
科学领域:
- 心脏病学
- 肝脏病学
- 内部医学
背景情况:
- 在心力衰竭 (HF) 患者中,低蛋白血症很常见,与不良结果相关.
- 病理生理因素包括营养不良,肝脏堵塞,炎症和失去蛋白质的肠病.
- 通过降低瘤压力,低蛋白会加剧HF症状和肺.
研究的目的:
- 检查高血压患者的低蛋白血症的病理生理学.
- 评估在HF治疗中对白蛋白输注的证据.
主要方法:
- 对心力衰竭中的低蛋白血症的文献综述.
- 对专治疗的病理生理机制和临床试验数据的分析.
主要成果:
- 胺补充剂可以促进尿液流失,但其整体疗效仍有争议.
- 常规使用白蛋白并不能改善HF患者的结果.
- 可以考虑选择性使用在强度低白血症的耐火性胀/ .
结论:
- 口服营养改善了营养不良HF患者的结果.
- 静脉胺治疗缺乏对HF治疗的明确指南.
- 需要进一步的研究来澄清白蛋白输注在特定HF群体中的作用.
相关概念视频
Heart Failure II: Pathophysiology
33
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
33
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Heart Failure VII: Nursing Interventions
139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure I: Introduction
49
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
49


